title: Remission of advanced EGFR-positive lung adenocarcinoma after short and intermittent erlotinib therapy.
authors: Sławomir
authors: S
authors: Mańdziuk
authors: Kamila
authors: K
authors: Wojas-Krawczyk
authors: Juliusz
authors: J
authors: Pankowski
authors: Magdalena
authors: M
authors: Jakubiak
authors: Leszek
authors: L
authors: Buk
authors: Paweł
authors: P
authors: Krawczyk
authors: Janusz
authors: J
authors: Milanowski
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D000077192:Adenocarcinoma of Lung; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000069347:Erlotinib Hydrochloride / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
chemical_list: D000964:Antimetabolites, Antineoplastic; D047428:Protein Kinase Inhibitors; D000069347:Erlotinib Hydrochloride